Cigna earnings: date, guidance and results
Cigna's next results are expected on November 5, 2026. The key thing to watch is whether Pharmacy Benefit Services’ earnings pressure is easing.
What has Cigna guided for 2026?
The company reaffirmed a target of at least $30.45 in adjusted earnings per share for 2026. Earnings per share divides profit among shareholders; adjusted earnings remove items management considers less representative of normal operations. In the second quarter, ordinary profit was $6.29 per share, while adjusted profit was $7.78 because Cigna excluded items such as acquired-intangible amortization, investment results and special charges. That can clarify recurring performance, but restructuring still costs real money.
Cigna Healthcare, the insurance business, is expected to provide at least $4,550 million of pre-tax adjusted operating income. Evernorth, which houses pharmacy and care services, is expected to provide at least $6,900 million. Yet pharmacy revenue rose 8% in the second quarter while Pharmacy Benefit Services’ adjusted operating income fell 27%. More prescriptions or more expensive drugs can increase revenue without increasing the fee left as profit.
| Period it covers | Low | High | Date given | |
|---|---|---|---|---|
| Consolidated Adjusted EPS | 2026 | 30.45 | Sep 30, 2026 | |
| Evernorth Health Services pre-tax adjusted income from operations | 2026 | 6,900 | Sep 30, 2026 | |
| Cigna Healthcare pre-tax adjusted income from operations | 2026 | 4,550 | Sep 30, 2026 | |
| Medical care ratio | 2026 | 83.7% | 84.7% | Sep 30, 2026 |
What this means. The $500 million in annualized after-tax savings is a yearly cost reduction, not a one-time payment, and some of it was already achieved in 2025.
Did Cigna keep its earnings promise?
Cigna did meet its shorter promise. Management guided to at least $29.60 in full-year adjusted earnings per share and delivered $29.84. “Adjusted” means Cigna excludes specified items from accounting profit, so meeting that target does not erase a miss on a longer-term measure.
How have Cigna's revenue and profit trended?
Core earnings increased about 6.4% from the prior year, while remaining almost unchanged from March. The quarterly series therefore suggests moderate improvement, not a steadily accelerating business.
Evernorth’s divisions moved in opposite directions. Pharmacy Benefit Services generated $34,496 million of revenue and $609 million of adjusted income. Specialty and Care Services produced $1,054 million of income. Drug mix lifted pharmacy revenue even as pharmacy activity declined, while specialty results benefited from Shields and operating efficiencies.
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | |
|---|---|---|---|---|---|
| Core earnings (company's measure) | 2,054 | 2,058 | 2,148 | 2,096 | 1,930 |
| Net income | 1,660 | 1,654 | 1,234 | 1,868 | 1,532 |
| EPS, diluted | 6.29 | 6.26 | 4.64 | 6.98 | 5.71 |